APHL 2021 Resources
Welcome to our resource page for the APHL 2021 Virtual Conference. Although we won’t be able to meet in person, we are pleased you are here!
Please explore this page to discover how Promega supports scientists working to understand the molecular mechanisms by which emerging viruses infect humans and animals, and to develop accurate detection methodology.
Coronavirus SARS-CoV-2 Detection and Assay Development
Promega is proud to offer multiple products that are authorized for use in numerous FDA Emergency Use Authorization assays, including the CDC’s 2019-nCoV RealTime RT-PCR Diagnostic Panel.
Viral Detection in Wastewater: The Future of Outbreak Prevention
Wastewater-based epidemiology (WBE), or sewershed surveillance, is the analysis of wastewater to identify presence of biologics or chemicals for the purpose of monitoring health. Learn about the advantages of SARS-CoV-2 wastewater surveillance and laboratory methods for detecting viral RNA.
Improving SARS-CoV-2 Antibody Detection with Bioluminescence
Bioluminescence offers many advantages when applied to antibody detection, including a simple, no-wash, easily automatable workflow. Learn how Promega harnessed our expertise in bioluminescence to develop a reliable, scalable and sensitive test for SARS-CoV-2 antibodies.
For decades Promega has been manufacturing reagents, assay, and benchtop instruments used in various kinds of virus research and testing alongside ~4,000 other manufactured and globally distributed products. Promega components currently support ~29 COVID-19 test kits, and we provide sample preparation tools to over 670 clinical labs worldwide.
More than 50 different Promega products are used by hospitals, Clinical Diagnostic labs, and molecular diagnostic manufacturers to support SARS-CoV-2 testing globally. Since January 2020, we have provided enough amplification reagents and enzymes to enable testing for an estimated 735 million samples for SARS-CoV-2 worldwide.